section name header

Pronunciation ⬇

SIM-va-sta-tin audio

Indications ⬆ ⬇

REMS

Action ⬆ ⬇

Therapeutic Effects:

Pharmacokinetics ⬆ ⬇

Absorption: 85% absorbed, but rapidly metabolized.

Distribution: Unknown.

Protein Binding: 95%.

Metabolism/Excretion: Extensively metabolized by the liver, most during first pass; excreted in bile and feces; 13% excreted unchanged by the kidneys.

Half-life: Unknown.

Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

CNS: amnesia, confusion, dizziness, headache, insomnia, memory loss, weakness.

GI: abdominal cramps, constipation, diarrhea, flatus, heartburn, altered taste, drug-induced hepatitis, dyspepsia, ↑ liver enzymes, nausea, pancreatitis.

GU: erectile dysfunction.

Derm: rashes, pruritus.

Endo: hyperglycemia.

MS: RHABDOMYOLYSIS, arthralgia, immune-mediated necrotizing myopathy, myopathy (↑ risk with 80 mg dose).

Misc: hypersensitivity reactions.

Interactions ⬆ ⬇

Drug-Drug:

Drug-Food:

Route/Dosage ⬆ ⬇

The 80 mg dose should be restricted to patients who have been taking this dose for ge.gif12 mo without evidence of muscle toxicity

Renal Impairment

Implementation ⬆ ⬇

US Brand Names ⬆ ⬇

FloLipid, Zocor

Classifications ⬆ ⬇

Therapeutic Classification: lipid-lowering agents

Pharmacologic Classification: hmg coa reductase inhibitors (statin)

Availability ⬆ ⬇

(Generic available)

Time/Action Profile ⬆ ⬇

(cholesterol-lowering effect)

ROUTEONSETPEAKDURATION†
POdays2–4 wkunknown

†After discontinuation.

Assessment ⬆ ⬇

Lab Test Considerations:

Pot. Nursing Diagnoses ⬆ ⬇

Patient/Family Teaching ⬆ ⬇

Evaluation/Desired Outcomes ⬆ ⬇

Pill Image

simvastatin_195_9191.jpg

Code ⬆

NDC Code*